1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib)
Publication
, Conference
Hong, DS; Bang, Y-J; Barlesi, F; Durm, GA; Falchook, GS; Govindan, R; Dy, GK; Park, K; Strickler, JH; Burns, TF; Kim, J; Ang, A; Lipford, JR ...
Published in: Annals of Oncology
September 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
September 2020
Volume
31
Start / End Page
S812 / S812
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Hong, D. S., Bang, Y.-J., Barlesi, F., Durm, G. A., Falchook, G. S., Govindan, R., … Li, B. T. (2020). 1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib). In Annals of Oncology (Vol. 31, pp. S812–S812). Elsevier BV. https://doi.org/10.1016/j.annonc.2020.08.1571
Hong, D. S., Y. -. J. Bang, F. Barlesi, G. A. Durm, G. S. Falchook, R. Govindan, G. K. Dy, et al. “1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib).” In Annals of Oncology, 31:S812–S812. Elsevier BV, 2020. https://doi.org/10.1016/j.annonc.2020.08.1571.
Hong DS, Bang Y-J, Barlesi F, Durm GA, Falchook GS, Govindan R, et al. 1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib). In: Annals of Oncology. Elsevier BV; 2020. p. S812–S812.
Hong, D. S., et al. “1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib).” Annals of Oncology, vol. 31, Elsevier BV, 2020, pp. S812–S812. Crossref, doi:10.1016/j.annonc.2020.08.1571.
Hong DS, Bang Y-J, Barlesi F, Durm GA, Falchook GS, Govindan R, Dy GK, Park K, Strickler JH, Burns TF, Kim J, Ang A, Lipford JR, Ngarmchamnanrith G, Anderson A, Li BT. 1257O Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib). Annals of Oncology. Elsevier BV; 2020. p. S812–S812.
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
September 2020
Volume
31
Start / End Page
S812 / S812
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis